CORRELATION OF RECIPIENT FACTORS WITH THE COURSE OF LYMPHOCYTES AFTER ALEMTUZUMAB INDUCTION IN RENAL TRANSPLANTATION

被引：0
|
作者：
Weissenbacher, A. [1 ]
Kimelman, M. [1 ]
Hautz, T. [1 ]
Ulmer, H. [2 ]
Boesmueller, C. [1 ]
Maglione, M. [1 ]
Margreiter, R. [1 ]
Oellinger, R. [1 ]
Pratschke, J. [1 ]
Schneeberger, S. [1 ]
机构：
[1] Med Univ Innsbruck, Univ Klin Visceral Transplantat & Thoraxchirurg, Innsbruck, Austria
[2] Med Univ Innsbruck, Dept Med Stat Informat & Gesundheitsokon, Innsbruck, Austria
来源：
TRANSPLANT INTERNATIONAL | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [1] Correlation of Recipient Factors with the Course of Lymphocytes after Alemtuzumab Induction in Renal Transplantation
    Weissenbacher, A.
    Kimelman, M.
    Hautz, T.
    Ulmer, H.
    Boesmueller, C.
    Maglione, M.
    Margreiter, R.
    Oellinger, R.
    Pratschke, J.
    Schneeberger, S.
    TRANSPLANTATION, 2012, 94 (10) : 984 - 984
  • [2] Correlation of Recipient Factors with the Course of Lymphocytes after Alemtuzumab Induction in Renal Transplantation.
    Weissenbacher, A.
    Kimelman, M.
    Hautz, T.
    Ulmer, H.
    Boesmueller, C.
    Maglione, M.
    Margreiter, R.
    Oellinger, R.
    Pratschke, J.
    Schneeberger, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 316 - 316
  • [3] Alemtuzumab Induction in Renal Transplantation
    Hanaway, Michael J.
    Woodle, E. Steve
    Mulgaonkar, Shamkant
    Peddi, V. Ram
    Kaufman, Dixon B.
    First, M. Roy
    Croy, Richard
    Holman, John
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (20): : 1909 - 1919
  • [4] Allograft Failure After Alemtuzumab Induction in Renal Transplantation.
    Willicombe, M.
    Goodall, D.
    Charif, R.
    Galliford, J.
    McLean, A.
    Taube, D.
    TRANSPLANTATION, 2014, 98 : 581 - 581
  • [5] Allograft Failure After Alemtuzumab Induction in Renal Transplantation.
    Willicombe, M.
    Goodall, D.
    Charif, R.
    Galliford, J.
    McLean, A.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 581 - 581
  • [6] Earlier Repletion of Lymphocytes After Alemtuzumab Induction Is Associated with a Lower Incidence of Infection Following Renal Transplantation.
    Willicombe, M.
    Goodall, D.
    McLean, A.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 282 - 282
  • [7] Fungal and mycobacterial infections after Campath (alemtuzumab) induction for renal transplantation
    Walsh, R.
    Ortiz, J.
    Foster, P.
    Palma-Vargas, J.
    Rosenblatt, S.
    Wright, F.
    TRANSPLANT INFECTIOUS DISEASE, 2008, 10 (04) : 236 - 239
  • [8] Infectious complications after renal transplantation utilizing alemtuzumab induction.
    Walker, Jennifier K.
    Afaneh, Cheguevara I.
    Gallon, Lorenzo G.
    Kaufman, Dixon B.
    Stosor, Valentina
    Ison, Michael G.
    Leventhal, Joseph R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 503 - 504
  • [9] Leukopenia complicates cytomegalovirus prevention after renal transplantation with alemtuzumab induction
    Walker, Jennifer K.
    Scholz, Lisa M.
    Scheetz, Marc H.
    Gallon, Lorenzo G.
    Kaufman, Dixon B.
    Rachwalski, Erik J.
    Abecassis, Michael M.
    Leventhal, Joseph R.
    TRANSPLANTATION, 2007, 83 (07) : 874 - 882
  • [10] Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab
    Kirk, AD
    Hale, DA
    Swanson, SJ
    Mannon, RB
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (05) : 1084 - 1085
12345